Efnim SP 100mg/325mg/15mg Tablet

By Efnim SP

Rx

10 Tablet in a Strip

Composition icon

Composition

Nimesulide(100mg) + Paracetamol(325mg) + Serratiopeptidase(15mg)

Manufacturer - Elcliff Formulations Pvt Ltd icon

Manufacturer - Elcliff Formulations Pvt Ltd

SCO 9, District Sub Center, TDL complex, Yamuna Nagar, Haryana – 135001 , India.

Expires on or after icon

Expires on or after

September, 2026

About Efnim SP 100mg/325mg/15mg Tablet

Efnim SP 100mg/325mg/15mg Tablet is a combined medication that effectively relieves pain by blocking the release of specific chemical messengers responsible for pain, inflammation, and fever in various health conditions. Additionally, it aids in healing at the site of inflammation. It is recommended to consume Efnim SP 100mg/325mg/15mg Tablet with food to avoid stomach upset. The dosage prescribed will vary depending on the condition being treated and the individual's response to the treatment. It is crucial to strictly follow the doctor's instructions and not exceed the prescribed dosage or duration of use.

Potential side effects of Efnim SP 100mg/325mg/15mg Tablet may include nausea, vomiting, diarrhea, stomach pain, elevated liver enzymes, and heartburn. If any of these side effects persist or worsen, it is advised to inform your doctor promptly. Your healthcare provider may provide guidance on ways to manage or alleviate these side effects. Prior to initiating treatment with Efnim SP 100mg/325mg/15mg Tablet, inform your doctor if you have a history of stomach ulcers or bleeding, high blood pressure, or any existing heart, kidney, or liver issues. Disclose all other medications you are currently taking to avoid any potential interactions.

Pregnant or breastfeeding individuals should consult with their healthcare provider before commencing treatment with Efnim SP 100mg/325mg/15mg Tablet. It is advisable to refrain from alcohol consumption while using this medication, as alcohol intake can lead to excessive drowsiness. Notably, as per the Ministry of Health and Family Welfare guidelines, Efnim SP 100mg/325mg/15mg Tablet is prohibited for children under the age of 12.


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

42.5

50

15% OFF

Inclusive of all taxes

Content verified by

chevron-right

Dr. Preeti Kumar

MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology

Last update on 01-Oct-2024